Top Markets
#1 Decred Decred +10.19%
#2 Wibx Wibx +9.06%
#3 Status Status +7.37%
#4 aelf aelf +5.49%
#5 SkyAI SkyAI +4.75%
#6 MarsCoin MarsCoin +4.32%
#7 Rei Rei +4.03%
#8 Robinhood Wrapped ETH (Robinhood Chain) Robinhood Wrapped ETH (Robinhood Chain) +3.86%
#9 TRIA TRIA +3.71%
#10 Humanity Humanity +3.23%
Coin of the day
Decred Decred
Настройки
Язык
Pусский
Валюта
USD
Тема
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Ранг среди акций #30680
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Цена акции
$0.91968646
Последняя синхронизация: 2026-08-18
Рыночная капитализация
$15.91M
Изменение (1 день)
2.23%
Изменение (1 год)
-52.75%
Страна
KR
Торговля Xcell Therapeutics, Inc. (373110)

Категория

Healthcare
Коэффициент P/S для Xcell Therapeutics, Inc. (373110)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Xcell Therapeutics, Inc., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Xcell Therapeutics, Inc. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE